 |
Email:
|
peter.solar@upjs.sk |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/peter.solar | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
ULBL
-
Department of Medical Biology
|
|
|
Office:
|
MA6O618 | |
|
Phone:
|
+421 55 234 3542 | |
|
ORCID ID:
|
0000-0002-1287-2979 |
|
Profile courses
|
|
Biológia 1, 2 - Všeobecné lekárstvo, I., II. degree
|
|
Biology 1, 2 - General Medicine, I., II. degree
|
|
Medical and human biology 1, 2 - Dental Medicine, I., II. degree
|
|
Lekárska a humánna biológia 1, 2 - Zubné lekárstvo, I., II. degree
|
|
Selected publications
|
|
ADC - Tóthová Z., Tomc J., Debeljak N., Solár P., STAT5 as a Key protein of erythropoietin signalization, Int. J. Mol. Sci. 22 (2021), art. no. 7109. IF=6,208, Q1. Cited: 20 times |
|
ADC - Tóthová Z., Šemeláková M., Solárová Z., Tomc J., Debeljak N., Solár P., The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization, Int. J. Mol. Sci. 22, č. 14 (2021), art. no. 7682. IF=6,208, Q1. Cited: 48 times |
|
V3 - Demečková V., Mudroňová D., Gancarčíková S., Kubatka P., Kajo K., Kassayová M., Bojková B., Adamkov M., Solár P., 5-fluorouracil treatment of CT26 colon cancer is compromised by combined therapy with Immodin, Int. J. Mol. Sci. 23 (2022), art. no. 6374. IF=5,6, Q1. Cited: 5 times |
|
V3 - Tóthová Z., Šemeláková M., Bhide K., Bhide M. R., Kováč A., Majerová P., Kvaková M., Štofilová J., Solárová Z., Solár P., Differentially expressed genes induced by erythropoietin receptor overexpression in rat mammary adenocarcinoma RAMA 37-28 cells, Int. J. Mol. Sci. 24 (2023), art. no. 8482. . IF=4,9, Q1. Cited: 0 times |
|
V3 - Bago Pilátová M., Solárová Z., Mezencev R., Solár P., Ceramides and their roles in programmed cell death, Adv. Med. Sci. 68 (2023) 417-425. IF=2,5, Q3. Cited: 11 times |
|
V3 - Mazuráková A., Solárová Z., Lacková L., Čaprnda M., Prosecký R., Khakymov A., Baranenko D., Kubatka P., Mirossay L., Kružliak P., Solár P., Heat shock proteins in cancer - Known but always being rediscovered, Adv. Med. Sci. 6 (2023) 464-473. IF=2,5, Q3. Cited: 3 times |
|
Selected projects
|
|
VEGA 1/0394/15: Erythropoietin receptor in mammary adenocarcinoma and its role in tamoxifen resistance, grant project leader. |
|
VEGA 1/0536/19: The role of the erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo, leader of the grant project. |
|
ASFEU project: "Innovation of the technological process of preparation of the immunomodulatory preparation Transfer factor, verification of its effectiveness, safety and composition" (ITMS code 26220220157), leader and project manager. |
|
VEGA 1/0500/23: Erytropoetínový receptor a jeho význam v signalizácii nádorovej bunky |
|
KEGA 024UPJŠ-4/202: Zavedenie praktických kurzov biomedicínskeho výskumu pre doktorandov a integrácia vedeckých pracovníkov do nových výučbových prístupov „PraktikMed" |
|
International mobilities and visits
|
|
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, 2002 - 2003, postdoc stay
|
|
University of Ljubljana, Ljubljana, Slovenia, 1.7.2019 - 6.7.2019, Erasmus+
|
|
Haskoli Islands, Reykjavik, Island, 30.8.2023 - 6.9.2023, Erasmus+
|
|
Awards
|
|
2007 - Avon Scholar Award: American Association for Cancer Research Conference
|
|
Projects
|
|
2005-2007 Slovenská agentúra pre podporu vedy a výskumu
APVV-20-012104: "The influence of erythropoietin on the growth of tumours in vitro and in vivo" 2006-2008 Vedecká grantová agentúra Ministersta školstva a Slovenskej akadémie vied VEGA 1/3253/06: "Molecular and biological substance of erythropoietin undesirable effect in the therapy of cancer cell" |
|
International collaboration
|
|
Institute of Biophysics, Czech Academy of Sciences, Brno, Czech Republic
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia |
